JP5825803B2 - Oil composition - Google Patents
Oil composition Download PDFInfo
- Publication number
- JP5825803B2 JP5825803B2 JP2011041589A JP2011041589A JP5825803B2 JP 5825803 B2 JP5825803 B2 JP 5825803B2 JP 2011041589 A JP2011041589 A JP 2011041589A JP 2011041589 A JP2011041589 A JP 2011041589A JP 5825803 B2 JP5825803 B2 JP 5825803B2
- Authority
- JP
- Japan
- Prior art keywords
- oil
- monoacylglycerol
- mass
- fatty acid
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 49
- 239000003921 oil Substances 0.000 claims description 65
- 239000003925 fat Substances 0.000 claims description 62
- 150000002759 monoacylglycerols Chemical class 0.000 claims description 55
- 150000001982 diacylglycerols Chemical class 0.000 claims description 39
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 claims description 31
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 27
- 229930195729 fatty acid Natural products 0.000 claims description 27
- 239000000194 fatty acid Substances 0.000 claims description 27
- 150000004665 fatty acids Chemical class 0.000 claims description 22
- 235000013305 food Nutrition 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 16
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 14
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 14
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 13
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 13
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 13
- 239000005642 Oleic acid Substances 0.000 claims description 13
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 13
- 239000000470 constituent Substances 0.000 claims description 12
- 239000003963 antioxidant agent Substances 0.000 claims description 4
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- 235000021588 free fatty acids Nutrition 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 description 60
- 235000019197 fats Nutrition 0.000 description 51
- 235000021313 oleic acid Nutrition 0.000 description 12
- 230000001766 physiological effect Effects 0.000 description 9
- -1 ricinoleic acid ester Chemical class 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 6
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 125000002252 acyl group Chemical group 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 235000002378 plant sterols Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- RZRNAYUHWVFMIP-QJRAZLAKSA-N 1-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)CO RZRNAYUHWVFMIP-QJRAZLAKSA-N 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- 125000001531 monoacylglycerol group Chemical group 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 150000002889 oleic acids Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 235000010692 trans-unsaturated fatty acids Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Edible Oils And Fats (AREA)
Description
本発明は、室温で液状の油脂組成物に関する。 The present invention relates to an oil and fat composition that is liquid at room temperature.
モノアシルグリセロールは、乳化剤として食品や医薬品、化粧品等に広く用いられている安全性に優れた物質である。
近年、モノアシルグリセロールの構造やモノアシルグリセロールを構成するアシル基の種類に着目した種々の機能を有する油脂が提案され、例えば、部分グリセリド(モノグリセリドおよびジグリセリド)の合計がトリグリセリドより多いグリセリド組成をもつ、高度不飽和脂肪酸を高濃度に含有する油脂自体に乳化性を付与した不飽和脂肪酸含有油脂組成物(特許文献1)が報告されている。また、構成アシル基中のω3系不飽和アシル基含量が15重量%以上であるジグリセリド及び/又はモノグリセリドを5重量%以上含有する油脂(特許文献2)や、構成脂肪酸として炭素数20未満のω3系、ω9系及びω6系の不飽和脂肪酸を特定量含むモノグリセリドと、モノグリセリドに対し一定の割合のジグリセリドを含有する油脂組成物(特許文献3)等が報告されている。
Monoacylglycerol is a highly safe substance widely used as an emulsifier in foods, pharmaceuticals, cosmetics and the like.
In recent years, fats and oils having various functions focused on the structure of monoacylglycerol and the type of acyl group constituting monoacylglycerol have been proposed. An unsaturated fatty acid-containing oil and fat composition (Patent Document 1) in which emulsifiability is imparted to an oil and fat itself containing a highly unsaturated fatty acid in a high concentration has been reported. Moreover, the fats and oils (patent document 2) which contain 5 weight% or more of diglycerides and / or monoglycerides whose content of ω3 unsaturated acyl groups in the structural acyl group is 15% by weight or more, and ω3 having less than 20 carbon atoms as a constituent fatty acid. An oil composition (Patent Document 3) containing monoglyceride containing a specific amount of a series, ω9 and ω6 unsaturated fatty acid, and a diglyceride in a certain ratio to the monoglyceride has been reported.
一方、油脂を構成する脂肪酸残基におけるオレイン酸は栄養学上好ましい脂肪酸とされ、健康志向への高まりに伴ってオレイン酸比率を高くした食用油脂が消費者に望まれている。
モノアシルグリセロールについても、1−モノオレインが、血清トリグリセリド濃度低下作用、食後のGIP分泌抑制作用を有することが知られている(特許文献4、5)。
On the other hand, oleic acid in fatty acid residues constituting fats and oils is considered to be a nutritionally preferable fatty acid, and edible fats and oils having a higher oleic acid ratio with increasing health consciousness are desired by consumers.
As for monoacylglycerol, 1-monoolein is known to have a serum triglyceride concentration lowering action and a postprandial GIP secretion inhibiting action (Patent Documents 4 and 5).
しかしながら、従来の構成脂肪酸中のオレイン酸含量が高いモノアシルグリセロールは、室温で固体であるため、使用時に加熱溶解しなければならず、取扱いが容易ではなく、加工法や用途が限定されるという問題があった。また、モノアシルグリセロールを食品の一部として含有させる場合、結晶が析出して不均一となり、所望量を摂取させることが難しくなる上に、食感も悪くなる。 However, since the conventional monoacylglycerol having a high oleic acid content in the constituent fatty acid is solid at room temperature, it must be dissolved by heating at the time of use, handling is not easy, and processing methods and applications are limited. There was a problem. In addition, when monoacylglycerol is contained as a part of food, crystals are precipitated and become non-uniform, making it difficult to ingest a desired amount and worsening the texture.
従って、本願発明の課題は、構成脂肪酸中のオレイン酸含量が高いモノアシルグリセロールを含有しながらも、室温で液状の油脂組成物を提供することにある。 Accordingly, an object of the present invention is to provide a fat and oil composition that is liquid at room temperature while containing monoacylglycerol having a high oleic acid content in the constituent fatty acids.
本発明者は、上記課題について鋭意検討を重ねた結果、モノアシルグリセロールとジアシルグリセロール及びトリアシルグリセロールをそれぞれ特定量含み、かつモノアシルグリセロールの含有量とジアシルグリセロールの含有量とが一定の関係を満たす油脂組成物であれば、室温下でも結晶化が抑えられ、液状が保たれることを見出した。 As a result of intensive studies on the above problems, the present inventor has included specific amounts of monoacylglycerol, diacylglycerol, and triacylglycerol, respectively, and the content of monoacylglycerol and the content of diacylglycerol have a certain relationship. It was found that if the oil / fat composition is filled, crystallization is suppressed even at room temperature and the liquid state is maintained.
すなわち、本発明は、室温で液状の油脂組成物であって、構成脂肪酸の60質量%以上がオレイン酸であるモノアシルグリセロールを4〜40質量%、ジアシルグリセロールを3〜96質量%及びトリアシルグリセロールを0〜90質量%含有し、かつモノアシルグリセロールの含有量Y(質量%)と、ジアシルグリセロールの含有量X(質量%)とが、次式(1)の関係を満たす油脂組成物を提供するものである。 That is, the present invention is an oil and fat composition that is liquid at room temperature, wherein 4 to 40% by mass of monoacylglycerol, 3 to 96% by mass of diacylglycerol, and triacylglycerol in which 60% by mass or more of the constituent fatty acids are oleic acid. An oil and fat composition containing 0 to 90% by mass of glycerol, and the content Y (% by mass) of monoacylglycerol and the content X (% by mass) of diacylglycerol satisfy the relationship of the following formula (1): It is to provide.
(数1)
Y<X+6 (1)
(Equation 1)
Y <X + 6 (1)
本発明によれば、構成脂肪酸中のオレイン酸含量が高いモノアシルグリセロールを高濃度に含有するものでありながら、室温で透明性を保ち外観が良好な液状の油脂組成物が得られる。 According to the present invention, it is possible to obtain a liquid oil composition having a good appearance while maintaining transparency at room temperature while containing a high concentration of monoacylglycerol having a high oleic acid content in the constituent fatty acids.
本発明の油脂組成物は室温で液状である。ここで、室温は23℃とする。液状とは、流動性を有している状態とする。 The oil and fat composition of the present invention is liquid at room temperature. Here, room temperature shall be 23 degreeC. The liquid state is a state having fluidity.
本発明の油脂組成物は、植物性油脂、動物性油脂のいずれを原料とするものでもよい。具体的な原料としては、例えば、大豆油、ナタネ油、サフラワー油、米糠油、コーン油、パーム油、ヒマワリ油、綿実油、オリーブ油、ゴマ油、シソ油等の植物性油脂、更に魚油、ラード、牛脂、バター脂等の動物性油脂、あるいはそれらのエステル交換油、水素添加油、分別油等の油脂類を挙げることができる。これらの油は、それぞれ単独で用いてもよく、あるいは適宜混合して用いてもよい。 The oil and fat composition of the present invention may be made from either vegetable oil or animal fat. Specific raw materials include, for example, vegetable oils such as soybean oil, rapeseed oil, safflower oil, rice bran oil, corn oil, palm oil, sunflower oil, cottonseed oil, olive oil, sesame oil, perilla oil, fish oil, lard, Examples thereof include animal fats and oils such as beef tallow and butter fat, and fats and oils such as transesterified oil, hydrogenated oil and fractionated oil. These oils may be used alone or in combination as appropriate.
本発明の油脂組成物は、モノアシルグリセロール及びジアシルグリセロールを含むものである。また、トリアシルグリセロールを含んでいてもよい。
油脂組成物中、モノアシルグリセロールの含有量は4〜40質量%(以下、単に「%」とする)であるが、4〜39%、更に10〜39%、特に15〜38%、殊更20〜35%であるのが生理効果発現の点、低温での保存性、風味の点から好ましい。
The oil and fat composition of the present invention contains monoacylglycerol and diacylglycerol. Triacylglycerol may also be included.
In the oil and fat composition, the content of monoacylglycerol is 4 to 40% by mass (hereinafter simply referred to as “%”), but is 4 to 39%, more preferably 10 to 39%, particularly 15 to 38%, and particularly 20 It is preferably -35% from the viewpoint of manifesting physiological effects, storage at low temperatures, and flavor.
モノアシルグリセロールを構成する脂肪酸のうち、オレイン酸の含有量は60%以上である。生理効果発現の点、酸化安定性の点から、オレイン酸の含有量は、更に78〜95%、特に80〜85%であることが好ましい。
残余の構成脂肪酸としては、飽和脂肪酸又は不飽和脂肪酸のいずれであってもよいが、構成脂肪酸中の80〜100%が不飽和脂肪酸であることが好ましく、より好ましくは82〜95%、さらに83〜90%であるのが外観、油脂の工業的生産性の点で好ましい。不飽和脂肪酸の炭素数は14〜24、さらに16〜22であるのが生理効果の点から好ましい。
Of the fatty acids constituting monoacylglycerol, the content of oleic acid is 60% or more. From the viewpoint of manifestation of physiological effects and oxidation stability, the content of oleic acid is preferably 78 to 95%, more preferably 80 to 85%.
The remaining constituent fatty acid may be either a saturated fatty acid or an unsaturated fatty acid, but 80 to 100% of the constituent fatty acids are preferably unsaturated fatty acids, more preferably 82 to 95%, and further 83. ˜90% is preferable in terms of appearance and industrial productivity of fats and oils. The number of carbon atoms of the unsaturated fatty acid is preferably 14 to 24, and more preferably 16 to 22 from the viewpoint of physiological effects.
また、モノアシルグリセロールを構成する脂肪酸のうち、飽和脂肪酸の含有量は0〜20%であることが好ましく、より好ましくは2〜18%、さらに5〜15%であるのが、外観、生理効果、油脂の工業的生産性の点で好ましい。飽和脂肪酸としては、炭素数14〜24、特に16〜22のものが好ましい。 In addition, among fatty acids constituting monoacylglycerol, the content of saturated fatty acids is preferably 0 to 20%, more preferably 2 to 18%, and even more preferably 5 to 15%. From the viewpoint of industrial productivity of fats and oils. The saturated fatty acid is preferably those having 14 to 24 carbon atoms, particularly 16 to 22 carbon atoms.
また、モノアシルグリセロールを構成する脂肪酸する脂肪酸のうち、トランス不飽和脂肪酸の含有量は、0〜4%、好ましくは0.1〜3.5%、さらに0.2〜3%であるのが風味、生理効果、外観、油脂の工業的生産性の点で好ましい。また、オレイン酸がトランス型となったもの、すなわちエライジン酸の含有量は、生理効果の点から1%以下が好ましく、0.5%以下がより好ましく、0.3%以下がさらに好ましい。 The content of trans-unsaturated fatty acids among the fatty acids constituting the monoacylglycerol is 0 to 4%, preferably 0.1 to 3.5%, and more preferably 0.2 to 3%. It is preferable in terms of flavor, physiological effect, appearance, and industrial productivity of fats and oils. Further, the content of oleic acid in trans form, that is, the content of elaidic acid is preferably 1% or less, more preferably 0.5% or less, and further preferably 0.3% or less from the viewpoint of physiological effects.
本発明の油脂組成物中、ジアシルグリセロールの含有量は3〜96%である。モノアシルグリセロールの油脂組成物への溶解性を向上させる点から、ジアシルグリセロールの含有量は10〜90%、更に30〜90%、特に40〜80%であるのが好ましい。なお、ジアシルグリセロールの構成脂肪酸は、モノアシルグリセロールと同様であることが、生理効果発現の点から好ましい。 In the oil and fat composition of the present invention, the content of diacylglycerol is 3 to 96%. From the viewpoint of improving the solubility of monoacylglycerol in the oil or fat composition, the content of diacylglycerol is preferably 10 to 90%, more preferably 30 to 90%, and particularly preferably 40 to 80%. The constituent fatty acid of diacylglycerol is preferably the same as monoacylglycerol from the viewpoint of manifesting physiological effects.
本発明の油脂組成物は、モノアシルグリセロールの含有量Y(%)とジアシルグリセロールの含有量X(%)とが、下記(1)式の関係を満たす。 In the oil and fat composition of the present invention, the monoacylglycerol content Y (%) and the diacylglycerol content X (%) satisfy the relationship of the following formula (1).
(数2)
Y<X+6 (1)
(Equation 2)
Y <X + 6 (1)
すなわち、モノアシルグリセロールの含有量Y(%)が、ジアシルグリセロールの含有量X(%)から式(1)により求められる値よりも小さいとき、室温で結晶化せず、透明で液状の油脂組成物が得られる。 That is, when the monoacylglycerol content Y (%) is smaller than the value obtained by the formula (1) from the diacylglycerol content X (%), it does not crystallize at room temperature and is a transparent and liquid oil composition. A thing is obtained.
さらに、モノアシルグリセロールの含有量Y(%)とジアシルグリセロールの含有量X(%)の関係が、次式(2)の関係を満たすことで、室温以下の温度、好ましくは20℃においても結晶化せず、透明で液状の油脂組成物が得られる。
(数3)
Y<X−2 (2)
Further, since the relationship between the monoacylglycerol content Y (%) and the diacylglycerol content X (%) satisfies the relationship of the following formula (2), the crystal is observed even at a temperature below room temperature, preferably 20 ° C. A transparent and liquid oil / fat composition is obtained.
(Equation 3)
Y <X-2 (2)
また、本発明の油脂組成物中、トリアシルグリセロールの含有量は、0〜90%であるが、モノアシルグリセロールの効果を最大限で発揮させる点で、10〜85%、更に10〜70%、特に15〜60%含有するのが好ましい。トリアシルグリセロールの構成脂肪酸は、モノアシルグリセロールと同様であることが、生理効果発現の点から好ましい。 Further, in the oil and fat composition of the present invention, the content of triacylglycerol is 0 to 90%, but 10 to 85%, more preferably 10 to 70%, in order to maximize the effect of monoacylglycerol. In particular, the content is preferably 15 to 60%. The constituent fatty acid of triacylglycerol is preferably the same as monoacylglycerol from the viewpoint of manifesting physiological effects.
また、本発明の油脂組成物は、遊離脂肪酸(塩)を含有してもよく、その含量は、5%以下が好ましく、さらに0〜2%、特に0〜1%であるのが風味、油脂の工業的生産性の点で好ましい。 Moreover, the fat and oil composition of the present invention may contain a free fatty acid (salt), and the content thereof is preferably 5% or less, more preferably 0 to 2%, and particularly preferably 0 to 1%. From the viewpoint of industrial productivity.
本発明の油脂組成物におけるモノアシルグリセロール(MAG)、ジアシルグリセロール(DAG)、トリアシルグリセロール(TAG)の含有質量比率の範囲は、図1に示したMAG、DAG、TAG三成分の三角図において、点a(MAG=4、DAG=96、TAG=0)、点b(MAG=40、DAG=60、TAG=0)、点c(MAG=40、DAG=34、TAG=26)、点d(MAG=9、DAG=3、TAG=88)、点e(MAG=7、DAG=3、TAG=90)及び点f(MAG=4、DAG=6、TAG=90)で囲まれる範囲内(但し、点cと点dを結んだ線分上を含まない)である。MAG、DAG、TAG三成分の含有質量比率を、斯かる範囲内とすることで、モノアシルグリセロールを構成する脂肪酸中のオレイン酸含量が高くても、室温で液状の油脂組成物が得られる。
当該MAG、DAG、TAGの含有質量比率の範囲は、生理効果発現の点、低温での保存性、油脂の工業的生産性の点から、好ましくは点a(MAG=4、DAG=96、TAG=0)、点b(MAG=40、DAG=60、TAG=0)、点h(MAG=40、DAG=42、TAG=18)及び点f(MAG=4、DAG=6、TAG=90)で囲まれる範囲内(但し、点hと点fを結んだ線分上を含まない)であり、更に好ましくは点i(MAG=10、DAG=90、TAG=0)、点b(MAG=40、DAG=60、TAG=0)、点h(MAG=40、DAG=42、TAG=18)、点j(MAG=28、DAG=30、TAG=42)及び点k(MAG=10、DAG=30、TAG=60)で囲まれる範囲内(但し、点hと点jを結んだ線分上を含まない)であり、特に好ましくは点l(MAG=20、DAG=80、TAG=0)、点b(MAG=40、DAG=60、TAG=0)、点h(MAG=40、DAG=42、TAG=18)及び点m(MAG=20、DAG=42、TAG=38)で囲まれる範囲内である。
The range of the mass ratio of monoacylglycerol (MAG), diacylglycerol (DAG), and triacylglycerol (TAG) in the oil and fat composition of the present invention is shown in the triangle diagram of the three components MAG, DAG, and TAG shown in FIG. , Point a (MAG = 4, DAG = 96, TAG = 0), point b (MAG = 40, DAG = 60, TAG = 0), point c (MAG = 40, DAG = 34, TAG = 26), point Range surrounded by d (MAG = 9, DAG = 3, TAG = 88), point e (MAG = 7, DAG = 3, TAG = 90) and point f (MAG = 4, DAG = 6, TAG = 90) Inside (however, the line segment connecting point c and point d is not included). By setting the mass ratio of the three components of MAG, DAG, and TAG within such a range, even if the oleic acid content in the fatty acid constituting monoacylglycerol is high, a liquid oil composition can be obtained at room temperature.
The range of the mass ratio of the MAG, DAG, and TAG is preferably point a (MAG = 4, DAG = 96, TAG) from the viewpoint of manifesting physiological effects, storage at low temperatures, and industrial productivity of fats and oils. = 0), point b (MAG = 40, DAG = 60, TAG = 0), point h (MAG = 40, DAG = 42, TAG = 18) and point f (MAG = 4, DAG = 6, TAG = 90) ) (But not on the line connecting point h and point f), more preferably point i (MAG = 10, DAG = 90, TAG = 0), point b (MAG = 40, DAG = 60, TAG = 0), point h (MAG = 40, DAG = 42, TAG = 18), point j (MAG = 28, DAG = 30, TAG = 42) and point k (MAG = 10) , DAG = 30, TAG = 60) And the point b (MAG = 20, DAG = 80, TAG = 0), point b (MAG = 40, DAG = 60, TAG = 0) are particularly preferable. , Point h (MAG = 40, DAG = 42, TAG = 18) and point m (MAG = 20, DAG = 42, TAG = 38).
本発明の油脂組成物には、保存性及び風味安定性の向上を目的として、抗酸化剤を添加することができる。抗酸化剤としては、天然抗酸化剤、トコフェロール、アスコルビン酸パルミテート、アスコルビン酸ステアレート、BHT、BHA、リン脂質等が挙げられる。 An antioxidant can be added to the oil and fat composition of the present invention for the purpose of improving storage stability and flavor stability. Antioxidants include natural antioxidants, tocopherols, ascorbyl palmitate, ascorbate stearate, BHT, BHA, phospholipids and the like.
また、本発明の油脂組成物には、調理品の食感又は風味の向上、生理機能付与等の点から乳化剤等を添加することができる。添加剤等としては、ポリグリセリン縮合リシノレイン酸エステル、ポリグリセリン脂肪酸エステル、ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル等のポリール脂肪酸エステル、有機酸モノグリセリド、植物ステロール、植物ステロールエステル等が挙げられる。 Moreover, the emulsifier etc. can be added to the oil-fat composition of this invention from points, such as the improvement of the food texture or flavor of cooking goods, and physiological function provision. Examples of additives include polyglycerin condensed ricinoleic acid ester, polyglycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, propylene glycol fatty acid ester and other polyol fatty acid esters, organic acid monoglycerides, plant sterols And plant sterol esters.
本発明の油脂組成物は、室温で液状であり、かつ栄養学上好ましいオレイン酸がモノアシルグリセロールを構成するアシル基として多く存在しているため、取扱性に優れ、また、優れた生理活性を有し、低濃度で作用し、風味良好である。そのため、本発明の油脂組成物は食品、飼料及び医薬品に利用することができる。 The oil and fat composition of the present invention is liquid at room temperature, and since there are many nutritionally preferred oleic acids as acyl groups constituting monoacylglycerol, it is excellent in handleability and has excellent physiological activity. Has a low concentration and good flavor. Therefore, the oil and fat composition of the present invention can be used for foods, feeds and pharmaceuticals.
食品としては、該油脂組成物を一般の食用油脂と同様に食品の一部として含有する油脂含有食品に用いることができる。かかる油脂含有食品としては、例えば、かかる油脂組成物を配合したカプセル剤、錠剤、顆粒剤、粉末剤;パン、ケーキ、クッキー等のベーカリー食品類;スープ類、ソース類、ドレッシング類、マヨネーズ類;クリーム類、チョコレート、キャンデー等の菓子や飲料等が挙げられる。かかる油脂含有食品は、上記油脂組成物の他に、油脂含有食品の種類に応じて一般に用いられる食品原料を添加して製造することができる。本発明の油脂組成物の食品への配合量は、食品の種類によっても異なるが、一般に0.1〜100%、特に1〜80%が好ましい。 As a food, the oil-and-fat composition can be used for an oil-and-fat-containing food containing the oil-and-fat composition as a part of the food in the same manner as a general edible oil and fat. Examples of such oil-containing foods include capsules, tablets, granules, powders containing such oil compositions; bakery foods such as bread, cakes, cookies; soups, sauces, dressings, mayonnaises; Examples include confectionery and beverages such as creams, chocolates, and candy. Such a fat-containing food can be produced by adding a food raw material generally used according to the type of the fat-containing food, in addition to the above fat composition. The amount of the oil / fat composition of the present invention to be added to food varies depending on the type of food, but is generally 0.1 to 100%, particularly preferably 1 to 80%.
飼料としては、例えば牛、豚、鶏、羊、馬、山羊等に用いる家畜用飼料、ウサギ、ラット、マウス等に用いる小動物用飼料、ウナギ、タイ、ハマチ、エビ等に用いる魚介類用飼料、犬、猫、小鳥、リス等に用いるペットフード等が挙げられ、本願発明の油脂組成物の他に一般に用いられる飼料原料とともに混合して製造することができる。本発明の油脂組成物の飼料への配合量は、用途等によっても異なるが、一般に1〜30%、特に1〜20%が好ましい。 As feed, for example, feed for livestock used for cattle, pigs, chickens, sheep, horses, goats, etc., feed for small animals used for rabbits, rats, mice, etc., feed for seafood used for eel, Thailand, hamachi, shrimp, etc. Examples include pet foods used for dogs, cats, small birds, squirrels, etc., and can be produced by mixing together with feed ingredients generally used in addition to the oil and fat composition of the present invention. Although the compounding quantity to the feed of the fat composition of this invention changes with uses etc., generally 1-30%, especially 1-20% are preferable.
また、医薬品としては、例えば散剤、顆粒剤、カプセル剤、丸剤、錠剤等の固形製剤、水剤、懸濁剤、乳剤等の液剤等の経口投与剤が挙げられる。この経口投与剤は、上記油脂組成物の他、経口投与剤の形態に応じて一般に用いられる賦形剤、崩壊剤、結合剤、滑沢剤、界面活性剤、アルコール類、水、水溶性高分子、甘味料、矯味剤、酸味料等を添加して製造することができる。経口投与用医薬品としては、脳機能改善剤等が挙げられる。本発明の油脂組成物の経口投与用医薬品への配合量は、医薬品の用途及び形態によっても異なるが、一般に0.1〜100%、特に1〜80%が好ましい。また、投与量は、油脂組成物として、1日当たり0.1〜50gを、1〜数回に分けて投与することが好ましい。 Examples of pharmaceuticals include solid preparations such as powders, granules, capsules, pills and tablets, and oral administration agents such as liquids such as liquids, suspensions and emulsions. In addition to the oil and fat composition described above, this oral administration agent includes excipients, disintegrants, binders, lubricants, surfactants, alcohols, water, water-soluble high-concentration agents that are generally used depending on the form of the oral administration agent. Molecules, sweeteners, flavoring agents, acidulants and the like can be added for production. Examples of the orally administered drug include a brain function improving agent. The blending amount of the oil and fat composition of the present invention into a pharmaceutical product for oral administration varies depending on the use and form of the pharmaceutical product, but is generally 0.1 to 100%, particularly preferably 1 to 80%. Moreover, it is preferable to administer 0.1-50g per day as an oil-fat composition divided into 1 to several times.
〔分析方法〕
(i)グリセリド組成
ガラス製サンプル瓶に、油脂サンプル約10mgとトリメチルシリル化剤(「シリル化剤TH」、関東化学製)0.5mLを加え、密栓し、70℃で15分間加熱した。これに水1.0mLとヘキサン1.5mLを加え、振とうした。静置後、上層をガスクロマトグラフィー(GLC)に供して分析した。
[Analysis method]
(I) Glyceride composition About 10 mg of an oil and fat sample and 0.5 mL of a trimethylsilylating agent (“silylating agent TH”, manufactured by Kanto Chemical) were added to a glass sample bottle, sealed, and heated at 70 ° C. for 15 minutes. To this, 1.0 mL of water and 1.5 mL of hexane were added and shaken. After standing, the upper layer was analyzed by gas chromatography (GLC).
(ii)構成脂肪酸組成
日本油化学会編「基準油脂分析試験法」中の「脂肪酸メチルエステルの調製法(2.4.1.−1996)」に従って脂肪酸メチルエステルを調製し、得られたサンプルを、American Oil Chemists.Society Official Method Ce 1f−96(GLC法)により測定した。
(Ii) Composition fatty acid composition Sample prepared by preparing fatty acid methyl ester in accordance with “Preparation method of fatty acid methyl ester (2.4.1.-1996)” in “Standard analysis method for fats and oils” edited by Japan Oil Chemists' Society Of American Oil Chemists. It was measured by Society Official Method Ce 1f-96 (GLC method).
〔原料油脂の調製〕
菜種油を加水分解して得た脂肪酸564gとグリセリン92gとを混合し、固定化1,3位選択リパーゼ(ノボルディスクインダストリー社製)を触媒としてエステル化反応を行った。リパーゼ製剤を濾別した後、反応終了品を分子蒸留し、更に脱色、水洗した後脱臭して、ジアシルグリセロール含有油脂を得た。これを原料油脂Bとして用いた。分析値を表1に示す。
また、原料油脂A、Cとして、表1の組成を持つ油脂を用いた。
[Preparation of raw oil and fat]
564 g of fatty acid obtained by hydrolyzing rapeseed oil and 92 g of glycerin were mixed, and an esterification reaction was carried out using immobilized 1,3-position selective lipase (manufactured by Novoldisk Industries) as a catalyst. After the lipase preparation was separated by filtration, the finished product was subjected to molecular distillation, further decolorized, washed with water, and deodorized to obtain a diacylglycerol-containing oil. This was used as the raw oil B. The analytical values are shown in Table 1.
Moreover, as raw material fats and oils A and C, fats and oils having the compositions shown in Table 1 were used.
原料油脂A〜Cを混合、溶解して油脂組成物をそれぞれ調製した。各油脂組成物のグリセリド組成及びモノアシルグリセロールの脂肪酸組成を表2に示す。 Raw material fats and oils A to C were mixed and dissolved to prepare respective fat and oil compositions. Table 2 shows the glyceride composition of each oil and fat composition and the fatty acid composition of monoacylglycerol.
〔外観の評価〕
各油脂組成物を調製後、20℃、23℃に1日保存した後の外観を、次の基準により目視にて評価した。結果を表2に示す。
[Appearance evaluation]
After each oil and fat composition was prepared, the appearance after storage at 20 ° C. and 23 ° C. for 1 day was visually evaluated according to the following criteria. The results are shown in Table 2.
外観の評価基準
1:清澄な状態
2:わずかに霞がかかった状態
3:一部結晶が析出、もしくは固化した状態
Appearance evaluation criteria 1: Clear state 2: Slightly wrinkled state 3: State of some crystals precipitated or solidified
表2に示された結果から明らかなように、本発明の油脂組成物は、構成脂肪酸中のオレイン酸含量が高いモノアシルグリセロールを含有しながらも、室温23℃で液状であり、透明性を保ち外観が良好であった。 As is clear from the results shown in Table 2, the oil and fat composition of the present invention contains a monoacylglycerol having a high oleic acid content in the constituent fatty acids, but is liquid at room temperature of 23 ° C. and has transparency. The keeping appearance was good.
Claims (5)
(数1)
Y<X+6 (1) It is a fat and oil that is liquid at room temperature, and is composed of 7 to 40% by mass of monoacylglycerol, 3 to 80% by mass of diacylglycerol, and 10 to 90% by mass of triacylglycerol in which 60% by mass or more of the constituent fatty acid is oleic acid, And the fats and oils whose content Y (mass%) of the monoacylglycerol whose 60 mass% or more of a constituent fatty acid is an oleic acid, and content X (mass%) of a diacylglycerol satisfy | fill the following formula (1).
(Equation 1)
Y <X + 6 (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011041589A JP5825803B2 (en) | 2011-02-28 | 2011-02-28 | Oil composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011041589A JP5825803B2 (en) | 2011-02-28 | 2011-02-28 | Oil composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012175948A JP2012175948A (en) | 2012-09-13 |
JP5825803B2 true JP5825803B2 (en) | 2015-12-02 |
Family
ID=46978286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011041589A Active JP5825803B2 (en) | 2011-02-28 | 2011-02-28 | Oil composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5825803B2 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10179086A (en) * | 1996-11-05 | 1998-07-07 | Riken Vitamin Co Ltd | Oil-solubilizing liquid containing plant sterol as well as drinks and their production |
JP4381037B2 (en) * | 2003-06-04 | 2009-12-09 | 花王株式会社 | Oil composition |
JP2005027505A (en) * | 2003-07-07 | 2005-02-03 | Toyo Seikan Kaisha Ltd | Package body where edible oil is charged in transparent plastic container |
JP2005257089A (en) * | 2004-03-09 | 2005-09-22 | Kao Corp | Cooking utensils for microwave oven |
JP2007037470A (en) * | 2005-08-03 | 2007-02-15 | Kao Corp | Method for producing flavor oil |
JP4589902B2 (en) * | 2006-09-07 | 2010-12-01 | 花王株式会社 | Oil composition |
JP4982421B2 (en) * | 2008-04-16 | 2012-07-25 | 花王株式会社 | Method for producing flavor oil |
-
2011
- 2011-02-28 JP JP2011041589A patent/JP5825803B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2012175948A (en) | 2012-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4381037B2 (en) | Oil composition | |
JP2018204038A (en) | Polyunsaturated fatty acid-containing solid fat compositions, and methods of uses and production thereof | |
CN1906280B (en) | A oil composition enriched in diglyceride with conjugated linoleic acid | |
US8853192B2 (en) | Fat or oil composition | |
BRPI0613295A2 (en) | oily product containing polyunsaturated fatty acid and uses and production thereof | |
EP1544281B1 (en) | Fat composition | |
US20100210723A1 (en) | Lipase inhibitor | |
TWI745512B (en) | Grease composition | |
JP2008069184A (en) | Oil-and-fat composition | |
JP5825803B2 (en) | Oil composition | |
JP4268473B2 (en) | Oil composition | |
Esperón-Rojas et al. | Structured acylglycerides emulsifiers with bioactive fatty acids as food ingredients | |
EP3884783B1 (en) | Oil and fat composition | |
JP2024051306A (en) | Fat composition | |
JP2015034130A (en) | Pharmaceutical fat composition improving stress emotion system disorder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20131219 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20141219 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150203 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150330 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150901 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150907 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20151006 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20151013 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 5825803 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |